Abstract:MicroRNAs (miRNAs) constitute a family of small non-coding ribonucleic acids that are post-transcriptional regulators of messenger RNA (mRNA) complexity. While miRNAs are known to be dynamically regulated during CNS development, the roles of specific miRNAs in CNS aging and neurodegeneration are not well understood. This study examined miRNA abundance and signaling circuitry in Alzheimer's disease (AD) brain, in cytokine-, Aβ42- and ROS-stressed human neural primary cell lines and in Tg2576 transgenic mice fed a high-fat cholesterol (HFC) diet. AD and age-matched control post-mortem brain tissue; IL-1β, Aβ42 and ROS-stressed human neural (HN) cells in primary culture; high-fat cholesterol (HFC) diet stressed Tg2576 mice; total DNA, RNA and protein isolation and quality control; DNA arrays (Affymetrix, Santa Clara, CA); micro RNA (miRNA) arrays (LC Sciences, Houston, TX); miRNA panels; Northern analysis; RT-PCR; Western Immunoblotting; gel shift assay; miRNA construct transfection vectors; specific NF–κB and inflammatory transcription factor repression; bioinformatics (Sanger miRBASE, Cambridge UK). Of the total number of miRNAs expressed in the human brain, only a selective subset appear to be altered in the AD process. miRNAs encoding miR-9, miR-124a, miR-125b, miR-128, miR-132 and miR-219 were found to be abundantly represented in fetal hippocampus however they exhibited differential regulation in Alzheimer hippocampus. Specific increases in the abundance of miRNA-146a was found to coincide with down-regulation in the abundance of one prominent miRNA-146a target, complement factor H (CFH) mRNA, encoding an important regulatory glycoprotein in the brain's complement and inflammatory response. Promoter mapping, inhibitor studies and transfection-reporter studies showed that miRNA-146a is an NF–κB-sensitive gene. We also observed a specific up-regulation of miRNA-146a in cytokine IL-1β- and Aβ42-stressed human neural cells and in HFC-stressed Tg2576 mice, an effect that was reversed in part by the cholesterol biosynthesis inhibitor simvastatin. These data are consistent with the idea that altered miRNA-mediated processing of mRNA populations may contribute to atypical mRNA abundance, neural dysfunction and inflammatory signaling pathways in Alzheimer's disease. The use of anti-miRNA pharmacotherapeutic strategies are attractive because they have potential to silence entire families of pro-inflammatory pathogenic genes in Alzheimer's disease brain. Supported in part by NIA AG18031.

Regulatory Factor X1 Depresses ApoE-dependent Aβ Uptake by Mirna-124 in Microglial Response to Oxidative Stress

Down‐regulated Expression of Microrna‐338‐5p Contributes to Neuropathology in Alzheimer's Disease

MicroRNA-139 Modulates Alzheimer's-associated Pathogenesis in SAMP8 Mice by Targeting Cannabinoid Receptor Type 2.

Mir-124 Downregulates Bace 1 and Alters Autophagy in App/Ps1 Transgenic Mice

Downregulation of miR-181c-5p in Alzheimer's disease weakens the response of microglia to Aβ phagocytosis

Genome-wide Analysis of Mirna Signature in the APPswe/PS1ΔE9 Mouse Model of Alzheimer's Disease.

O2-03-06: Micro RNA-146A–mediated Signaling in Alzheimer's Disease

MicroRNA-668-3p regulates oxidative stress and cell damage induced by Aβ1-42 by targeting the OXR1/p53-p21 axis

Nogo receptor impairs the clearance of fibril amyloid- by microglia and accelerates Alzheimer's-like disease progression

The Downregulation of ITGAX Exacerbates Amyloid-β Plaque Deposition in Alzheimer's Disease by Increasing Polarization of M1 Microglia

Silencing of LRP1 Exacerbates Inflammatory Response Via TLR4/NF-κB/MAPKs Signaling Pathways in APP/PS1 Transgenic Mice

miR-204-3p/Nox4 Mediates Memory Deficits in a Mouse Model of Alzheimer's Disease

miR-204-3p/Nox4 Mediates Memory Deficits in a Mouse Model of Alzheimer's Disease.

O3‐01‐05: MIR‐204 ATTENUATES MEMORY DEFICITS IN A MOUSE MODEL OF ALZHEIMER'S DISEASE

MiR-191-5p alleviates microglial cell injury by targeting Map3k12 (mitogen-activated protein kinase kinase kinase 12) to inhibit the MAPK (mitogen-activated protein kinase) signaling pathway in Alzheimer’s disease

The Microrna-1908 Up-Regulation in the Peripheral Blood Cells Impairs Amyloid Clearance by Targeting ApoE

Intrahippocampal Mir-342-3p Inhibition Reduces Β-Amyloid Plaques and Ameliorates Learning and Memory in Alzheimer's Disease.

The Mir-124 Regulates The Expression Of Bace1/Beta-Secretase Correlated With Cell Death In Alzheimer'S Disease

MicroRNAs 99B-5P/100-5p Regulated by Endoplasmic Reticulum Stress Are Involved in Abeta-Induced Pathologies.

Microglia prevent beta-amyloid plaque formation in the early stage of an Alzheimer’s disease mouse model with suppression of glymphatic clearance

Novel upregulation of amyloid-β precursor protein (APP) by microRNA-346 via targeting of APP mRNA 5′-untranslated region: Implications in Alzheimer’s disease